Search
Advanced Search
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2021
New Titles 2020
Price and Ordering Information
Subscription Rates 2021
Subscription Rates 2020
eBooks Website
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Marketing Opportunities
Institutional Membership
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2020
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Media Partners
Partnering Events
Promotional Services
For Authors, Editors & Librarians
Author Benefits
Author's Benefits Guide
Author Reprints
Authorship
Copyediting Services
Editorial Policies
FAQs for e-prints/reprints
Increase Visibility of your Article
General FAQs
Guidelines for Guest Editors
Journal Catalog 2020
Journal Catalog 2021
Kudos
Library Recommendations
Manuscript Transfer Facility
Online Manuscript Submission
Order Bulk ePrints
Order Bulk Reprints
Publication Cycle - Process Flowchart
Publishing Ethics
Peer Review
Self-Archiving Policies
Table of Contents Alert
Trial Requests
Webinars
Contact Us
Track Your Manuscript:
Enter Correct Manuscript Reference Number:
Submit Reference Number
Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Impact Factor:
2.912
5 Year Impact Factor:
2.947
Subscribe to this Journal
Call for Editors
Book Proposal
Join Editorial Board
New Journal Proposal
Become a Reviewer
Become an Executive Guest Editor
Thematic Issue Proposal
Submit Abstract Online
Contents
Current Cancer Drug Targets
,
Volume 20
- Number 11
Biography
Open Access
Meet Our Editorial Board Member
,
20
(
11
):
819
- 820
M. Zhou
DOI:
10.2174/156800962011201202144433
View Biography
Download Free
Review Article
Exosome as a Natural Gene Delivery Vector for Cancer Treatment
,
20
(
11
):
821
- 830
Prasad Pofali, Adrita Mondal and Vaishali Londhe*
DOI:
10.2174/1568009620666200924154149
×
Exosome as a Natural Gene Delivery Vector for Cancer Treatment
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
An Overview of Promising Biomarkers in Cancer Screening and Detection
,
20
(
11
):
831
- 852
Saba Hasan*
DOI:
10.2174/1568009620666200824102418
×
An Overview of Promising Biomarkers in Cancer Screening and Detection
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Review Article
Targeting Six Hallmarks of Cancer in Ovarian Cancer Therapy
,
20
(
11
):
853
- 867
Han Gong, Dan Nie and Zhengyu Li*
DOI:
10.2174/1568009620999200816130218
×
Targeting Six Hallmarks of Cancer in Ovarian Cancer Therapy
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Research Article
Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling
,
20
(
11
):
868
- 874
Zhi Li, Wen-Qi Gao, Peng Wang, Tian-Qi Wang, Wen-Chao Xu, Xin-Yu Zhu and Hui Liu*
DOI:
10.2174/1568009620999200730184514
×
Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Research Article
Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma
,
20
(
11
):
875
- 886
Yingyi Wang, Bao Jin, Na Zhou, Zhao Sun, Jiayi Li, Qiao Chen, Xiangan Wu, Yi Zhou, Yue Shi, Xin Lu, Xinting Sang, Yilei Mao, Shunda Du*, Wenze Wang* and Chunmei Bai*
DOI:
10.2174/1568009620999200918121456
×
Identification of WDFY3 Neoantigens as Prognostic Markers in Longterm Survivors of Extrahepatic Cholangiocarcinoma
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Clinical Trial
Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study
,
20
(
11
):
887
- 895
Martina Catalano, Giandomenico Roviello*, Raffaele Conca, Alberto D’Angelo, Valeria Emma Palmieri, Benedetta Panella, Roberto Petrioli, Anna Ianza, Stefania Nobili, Enrico Mini and Monica Ramello
DOI:
10.2174/1568009620999200918122426
×
Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study
View Abstract
Permissions
View on PubMed
Order Reprints
Order Eprints
View Abstract
More Options
Permissions
View on PubMed
Order Reprints
Order Eprints
Acknowledgement
Open Access
Acknowledgements to Reviewers
,
20
(
11
):
896
- 898
DOI:
10.2174/156800962011201202144526
Permissions
Order Reprints
Order Eprints
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board
COPE Compliant
About the Journal
⇨ Journal Home
⇨ Editorial Policies
⇨ Editorial Board
⇨ Meet the Executive Guest Editor(s)
⇨ Board Recruitment Workflow
⇨ Join Editorial Board
⇨ Indexing Information
⇨ Announcements
⇨ Endorsements
⇨ Authors' Comments
For Authors
⇨ Author Guidelines
⇨ Animated Abstracts
⇨ Increase Visibility of your Article
⇨ Submit Abstracts Online
⇨ Submit Manuscripts Online
⇨ Open Access Funding
⇨ Publishing Ethics and Rectitude
⇨ Archiving Policies
⇨ Manuscript Transfer Facility
For Guest Editors
⇨ Thematic Issue Proposal
⇨ Forthcoming Thematic Issues
⇨ Guest Editor Guidelines
For Reviewers
⇨ Reviewer Guidelines
⇨ Peer Review Workflow
⇨ Become a Reviewer
For Librarians & Readers
⇨ Contents & Abstracts
⇨ Open Access Articles
⇨ Editor's Choice
⇨ Free Copies Online
⇨ Thematic Issues
⇨ Journal Catalog 2020
⇨ Journal Catalog 2021
⇨ Most Accessed Articles
⇨ Most Cited Articles
⇨ PURCHASE ARTICLES
⇨ Order Reprints
⇨ Subscribe
⇨ Trial Requests
⇨ Library Recommendation
Quick Links
⇨ Journal's New Website
⇨ Advertise with Us
⇨ Brand Ambassadors
⇨ Newsletter
⇨ Download PDF Flyer
⇨ Table of Contents Alert
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Advertisement
Related Journals
view more >>
Related eBooks
view more >>
eBooks Catalog
view eBooks Catalog >>
Webmaster Contact:
info@benthamscience.net
Copyright © 2021 Bentham Science
|
Privacy Policy